Skip to main content

Noveris Health Sciences Inc.

corporate_fare Company Profile

Noveris Health Sciences Inc.

MYCOF·OTC·Life Sciences

Noveris Health Sciences Inc. is a biotechnology company focused on the research, development, and commercialization of psilocybin products for mental health conditions. The company's primary therapeutic areas are nicotine addiction and post-traumatic stress disorder. Noveris Health Sciences Inc. is also developing specific compounds, MYCO-005, MYCO-006, and MYCO-007, which are MDMA and psilocybin analogs. The company collaborates with Applied Pharmaceutical Innovation on pharmaceutical drug discovery, research, and development, specifically targeting empathogenic and entactogenic compounds. Incorporated in 2013, Noveris Health Sciences Inc. is headquartered in Vancouver, Canada. The company was previously known as Mydecine Innovations Group Inc. and officially changed its name to Noveris Health Sciences Inc. in February 2026.

Noveris Health Sciences Inc. (OTC:MYCOF) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 3 items for MYCOF at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-04-29, rated 8/10. Across its 3 most recent items scored 7 or higher, the top rating is 9/10, with 3 rated 8 or above.

Recent high-impact activity:

  • $1M Cash Deal: Noveris Health Sciences to Acquire 49% Stake in Stem Cell Distributor
  • BCSC Review Forces Noveris Health to Retract Key Business Claims, Amend Offering
  • Regulatory Halt Issued for MYCOF Shares Amid "Unusual Fluctuations" and Disavowal of Inaccurate Article
$0.73
52-week range · as of 2026-04-29 $0.005 – $1.4
Market cap
$12.86M
Volume
10K (3.9× avg)
3-mo avg 2.6K
Last traded · 2026-08-18

show_chartPrice Chart

Loading chart...

feed MYCOF - Latest Insights

MYCOF
Apr 29, 2026, 12:05 PM EDT
Source: The newswire.ca
Importance Score:
8
$1M Cash Deal: Noveris Health Sciences to Acquire 49% Stake in Stem Cell Distributor
Price at Filing: $1.00
Real-time Price: $0.730 info
Change: -$0.270 (-27%) info
Market Cap: $12.863M info
Sentiment: Neutral
View Wiseek Article
MYCOF
Apr 20, 2026, 5:25 PM EDT
Source: The newswire.ca
Importance Score:
9
BCSC Review Forces Noveris Health to Retract Key Business Claims, Amend Offering
Price at Filing: $1.32
Real-time Price: $0.730 info
Change: -$0.5875 (-45%) info
Market Cap: $12.863M info
Sentiment: Negative
View Wiseek Article
MYCOF
Mar 26, 2026, 4:45 PM EDT
Source: The newswire.ca
Importance Score:
9
Regulatory Halt Issued for MYCOF Shares Amid "Unusual Fluctuations" and Disavowal of Inaccurate Article
Price at Filing: $1.32
Real-time Price: $0.730 info
Change: -$0.5875 (-45%) info
Market Cap: $12.863M info
Sentiment: Negative
View Wiseek Article
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets